Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis

Nephron

Volumn 81, Issue 2, 1999, Pages 221-229

  Uhlenius, Nina ^a   Tikkanen, Tuula ^b   Miettinen, Aaro ^b   Holthöfer, Harry ^b   Törnroth, Tom ^b   Eriksson, Anders ^b   Fyhrquist, Frej ^b   Tikkanen, Ilkka ^b  

^a MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^b NONE

Author keywords

ACE inhibition; Heymann nephritis; Hypertension; Nitric oxide; Renoprotection

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME INHIBITION; FEMALE; HEART VENTRICLE HYPERTROPHY; HEYMANN NEPHRITIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; MEMBRANOUS GLOMERULONEPHRITIS; MONONUCLEAR CELL; MORTALITY; NEPHRITIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTECTION; PROTEINURIA; RAT; URINE LEVEL;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CAPTOPRIL; CYCLIC GMP; ENZYME INHIBITORS; FEMALE; GLOMERULONEPHRITIS; HYPERTENSION, RENAL; KIDNEY TUBULES; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; ORGAN SIZE; RATS; RATS, WISTAR; RENIN;

EID: 0033035160     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045280     Document Type: Article

References (36)

1. Erdös EG: Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-370.
2. Williams GH: Converting enzyme inhibitors in the treatment of hypertension. N Engl J Med 1988;319:1517-1525.
3. Farhy RD, Carretero OA, Ho K-L, Scicli AG: Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 1993;72:1202-1210.
4. Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL: Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992;20:240-248.
5. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A metaregression analysis. Ann Intern Med 1993;118: 129-138.
6. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76:612-619.
7. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
8. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-771.
9. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994;93: 2431-2437.
10. Cachofeiro V, Sakakibara T, Nasjletti A: Kinins, nitric oxide, and the hypertensive effect of captopril and ramiprilat in hypertension. Hypertension 1992;19:138-145.
11. Wang Y-X, Gavras I, Wierzba T, Lammek B, Gavras H: Inhibition of nitric oxide, bradykinin, and prostaglandins in normal rats. Hypertension 1992;19(suppl II):255-261.
12. Quilley J, Duchin KL, Hudes EM, McGiff JC: The antihypertensive effect of captopril in essential hypertension: Relationship to prostaglandins and the kallikrein-kinin system. J Hypertens 1987;5:121-128.
13. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90:278-281.
14. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992;20:298-303.
15. Raij L, Baylis C: Glomerular actions of nitric oxide. Kidney Int 1995;48:20-32.
16. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ: Angiotensin blockade preserves hypertension during long-term nitric oxide synthase inhibition. Hypertension 1993;21:660-666.
17. Arnal J-F, Warin L, Michel J-B: Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992;90: 647-652.
18. Miettinen A, Törnroth T, Tikkanen I, Virtanen I, Linder E: Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest 1980;43:547-555.
19. Uhlenius N, Tikkanen I, Tikkanen T, Miettinen A, Törnroth T, Fyhrquist F: Chronic inhibition of nitric oxide synthase in Heymann nephritis. Nephron 1996;74:144-149.
20. Bunag RD: Validation in awake rats of a tailcuff method for measuring systolic pressure. J Appl Physiol 1973;34:279-282.
21. Fyhrquist F, Soverti P, Puutula L, Stenman U-H: Radioimmunoassay of plasma renin acitivity.Clin Chem 1976;22:250-256.
22. Tikkanen I, Fyhrquist F, Puutula-Räsänen L: Enzyme inhibitors for renin assay in rat plasma. Clin Sci 1980;59:381-383.
23. Tikkanen I, Fyhrquist F, Metsärinne K, Leidenius R: Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet 1985;ii:66-69.
24. + when the Griess reaction is used to assay for nitrite. Anal Biochem 1995;224:502-508.
25. Burton C, Harris KPG: The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996;27:765-775.
26. Tolins JP, Palmer RMJ, Moncada S, Raij L: Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1990;258:H655-H662.
27. Schmidt HHHW, Lohmann SM, Walter U: The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1993;1178:153-175.
28. Wong KR, Xie M-H, Shi L-B, Liu F-Y, Huang C-L, Gardner DG, Cogan M: Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor. Am J Physiol 1988;255: F1220-F1224.
29. Sever R, Cook T, Cattell V: Urinary excretion of nitrite and nitrate in experimental glomerulonephritis reflects systemic immune activation and not glomerular synthesis. Clin Exp Immunol 1992;90:326-329.
30. Cattell V, Largen P, de Heer E, Cook T: Glomeruli synthesize nitrite in active Heymann nephritis; the source is infiltrating macrophages. Kidney Int 1991;40:847-851.
31. Jansen A, Cook T, Taylor GM, Largen P, Riveros-Moreno V, Moncada S, Cattell V: Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 1994; 45:1215-1219.
32. McLay JS, Chatterjee P, Nicolson AG, Jardine AG, McKay NG, Ralston SH, Grabowski P, Haites NE, MacLeod AM, Hawksworth GM: Nitric oxide production by human proximal tubular cells: A novel immunomodulatory mechanism? Kidney Int 1994;46:1043-1049.
33. Nord EP: Renal actions of endothelium. Kidney Int 1993;44:451-463.
34. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
35. Remuzzi A, Benigni A, Malanchini B, Bruzzi I, Foglieni C, Remuzzi G: ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats. Kidney Int 1995;47: 1319-1326.
36. Arnal J-F, El Amrani A-I, Chatellier G, Ménard J, Michel J-B: Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 1993;22:380-387.